Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
April 26, 2021 at 02:00 pm
Share
Beihai Gofar Marine Biological Industry Co., Ltd. announced earnings results for the fourth quarter ended December 31, 2020. For the year, the company announced sales was CNY 267.699 million compared to CNY 251.153 million a year ago. Operating income was CNY 8.822 million compared to CNY 9.567 million a year ago. Net income was CNY 3.200 million compared to CNY 5.772 million a year ago. Basic earnings per share from continuing operations was CNY 0.007 compared to CNY 0.012 a year ago. For the quarter, sales was CNY 94.013 million compared to CNY 58.873 million a year ago. Operating income was CNY 5.080 million compared to CNY 1.809 million a year ago. Net income was CNY 4.243 million compared to CNY 1.030 million a year ago. Basic earnings per share from continuing operations was CNY 0.008 compared to CNY 0.002 a year ago.
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.